Nanomedicines accessible in the market for clinical interventions
V Gadekar, Y Borade, S Kannaujia, K Rajpoot… - Journal of Controlled …, 2021 - Elsevier
Nanomedicines refers to nanotechnology inspired pharmaceutical products often referred to
as 'nanopharmaceuticals.'It has displayed commendable potential in enhancing therapeutic …
as 'nanopharmaceuticals.'It has displayed commendable potential in enhancing therapeutic …
Clinical utility of pegaspargase in children, adolescents and young adult patients with acute lymphoblastic leukemia: a review
C Bender, L Maese, M Carter-Febres… - Blood and Lymphatic …, 2021 - Taylor & Francis
Acute lymphoblastic leukemia (ALL) is a heterogenous hematological malignancy
representing 25% of all cancers in children less than 15 years of age. Significant …
representing 25% of all cancers in children less than 15 years of age. Significant …
Enhancement of enzyme activity by laser-induced energy propulsion of upconverting nanoparticles under near-infrared light: A comprehensive methodology for in …
If the appropriate immobilization method and carrier support are not selected, partial
decreases in the activity of enzymes may occur after immobilization. Herein, to overcome …
decreases in the activity of enzymes may occur after immobilization. Herein, to overcome …
From synthesis to characterization of site-selective PEGylated proteins
LH Belén, CO Rangel-Yagui… - Frontiers in …, 2019 - frontiersin.org
Covalent attachment of therapeutic proteins to polyethylene glycol (PEG) is widely used for
the improvement of its pharmacokinetic and pharmacological properties, as well as the …
the improvement of its pharmacokinetic and pharmacological properties, as well as the …
Heterologous expression and molecular modelling of L-asparaginase from Bacillus subtilis ETMC-2
Bacterial L-asparaginase is the key therapeutic enzyme in cancer therapy and is also
witnessing demand as a food processing aid. In this study, L-asparaginase of newly isolated …
witnessing demand as a food processing aid. In this study, L-asparaginase of newly isolated …
Covalent immobilization of L-asparaginase and optimization of its enzyme reactor for reducing acrylamide formation in a heated food model system
R Li, Z Zhang, X Pei, X Xia - Frontiers in bioengineering and …, 2020 - frontiersin.org
Acrylamide is a potent carcinogen and neurotoxin that is mainly formed by the Maillard
reaction of asparagine with starch at high temperatures. In this work, a food safety …
reaction of asparagine with starch at high temperatures. In this work, a food safety …
[HTML][HTML] In vivo stabilization of a less toxic asparaginase variant leads to a durable antitumor response in acute leukemia
M Van Trimpont, AM Schalk, Y De Visser… - …, 2023 - ncbi.nlm.nih.gov
Asparagine is a non-essential amino acid since it can either be taken up via the diet or
synthesized by asparagine synthetase. Acute lymphoblastic leukemia (ALL) cells do not …
synthesized by asparagine synthetase. Acute lymphoblastic leukemia (ALL) cells do not …
Enzyme Engineering Strategies for the Bioenhancement of l-Asparaginase Used as a Biopharmaceutical
Over the past few years, there has been a surge in the industrial production of recombinant
enzymes from microorganisms due to their catalytic characteristics being highly efficient …
enzymes from microorganisms due to their catalytic characteristics being highly efficient …
Development of a bioengineered Erwinia chrysanthemi asparaginase to enhance its anti-solid tumor potential for treating gastric cancer
SY Tam, SF Chung, CF Kim, JC To, PK So… - International Journal of …, 2023 - Elsevier
Asparaginase has been traditionally applied for only treating acute lymphoblastic leukemia
due to its ability to deplete asparagine. However, its ultimate anticancer potential for treating …
due to its ability to deplete asparagine. However, its ultimate anticancer potential for treating …
[HTML][HTML] Downstream process and evaluation of the concomitant impact of a recombinant glycosylated L-asparaginase on leukemic cancer cells and the bone marrow …
Abstract L-asparaginase (L-ASNase) is a life-saving medication used in the treatment of
Acute Lymphoblastic Leukemia (ALL) which affects over 60,000 people yearly. However, L …
Acute Lymphoblastic Leukemia (ALL) which affects over 60,000 people yearly. However, L …